Arnebin-1 accelerates normal and hydrocortisone-induced impaired wound healing
- PMID: 10571733
- DOI: 10.1046/j.1523-1747.1999.00761.x
Arnebin-1 accelerates normal and hydrocortisone-induced impaired wound healing
Abstract
Wound healing involves inflammation, cell proliferation, matrix deposition, and tissue remodeling. Interaction of different cells, extracellular matrix proteins, and their receptors are mediated by cytokines and growth factors during wound healing. In this study, we have evaluated the effect of arnebin-1, a natural product isolated from Arnebia nobilis, on normal and impaired wound healing in cutaneous punch wound model. Arnebin-1 was applied topically daily on wounds of hydrocortisone-treated or untreated animals. Arnebin-1 significantly accelerated healing of wounds with or without hydrocortisone treatment as revealed by a reduction in the wound width and gap length compared with controls. Arnebin-1 treatment promoted the cell proliferation, migration, and vessel formation to form a thick granulation tissue and re-epithelialization of the wounds. An increase in the synthesis of collagen, fibronectin and transforming growth factor-beta1 was seen in arnebin-1-treated wounds compared with the untreated control. As transforming growth factor-beta1 is known to enhance wound healing, and associated with the wound healing defect in hydrocortisone-treated wounds, the enhanced expression of transforming growth factor-beta1 at both translational and transcriptional level by arnebin-1 may be responsible for the enhancement of wound healing during normal and impaired wound repair. These studies suggest that arnebin-1 could be developed as a potent therapeutic agent for wound healing in steroid-impaired wounds.
Similar articles
-
Enhancement of wound healing by shikonin analogue 93/637 in normal and impaired healing.Skin Pharmacol Physiol. 2004 Jan-Feb;17(1):49-56. doi: 10.1159/000074063. Skin Pharmacol Physiol. 2004. PMID: 14755128
-
Arnebin-1 promotes the angiogenesis of human umbilical vein endothelial cells and accelerates the wound healing process in diabetic rats.J Ethnopharmacol. 2014 Jul 3;154(3):653-62. doi: 10.1016/j.jep.2014.04.038. Epub 2014 May 1. J Ethnopharmacol. 2014. PMID: 24794013
-
Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing.Biofactors. 2002;16(1-2):29-43. doi: 10.1002/biof.5520160104. Biofactors. 2002. PMID: 12515914
-
[The modern approach to wound treatment].Med Pregl. 2000 Jul-Aug;53(7-8):363-8. Med Pregl. 2000. PMID: 11214479 Review. Croatian.
-
The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).Eur J Surg Suppl. 1997;(577):17-23. Eur J Surg Suppl. 1997. PMID: 9076448 Review.
Cited by
-
Novel Biotherapeutics Targeting Biomolecular and Cellular Approaches in Diabetic Wound Healing.Biomedicines. 2023 Feb 18;11(2):613. doi: 10.3390/biomedicines11020613. Biomedicines. 2023. PMID: 36831151 Free PMC article. Review.
-
Wound healing effects of arnebia densiflora root extracts on rat palatal mucosa.Eur J Dent. 2009 Apr;3(2):96-9. Eur J Dent. 2009. PMID: 19421388 Free PMC article.
-
Effect of Topical Administration of Fractions and Isolated Molecules from Plant Extracts on Skin Wound Healing: A Systematic Review of Murine Experimental Models.Mediators Inflamm. 2016;2016:4916068. doi: 10.1155/2016/4916068. Epub 2016 Oct 17. Mediators Inflamm. 2016. PMID: 27829707 Free PMC article. Review.
-
Review of Shikonin and Derivatives: Isolation, Chemistry, Biosynthesis, Pharmacology and Toxicology.Front Pharmacol. 2022 Jul 1;13:905755. doi: 10.3389/fphar.2022.905755. eCollection 2022. Front Pharmacol. 2022. PMID: 35847041 Free PMC article. Review.
-
Phytochemicals in Wound Healing.Adv Wound Care (New Rochelle). 2016 May 1;5(5):230-241. doi: 10.1089/wound.2013.0505. Adv Wound Care (New Rochelle). 2016. PMID: 27134766 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous